Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.98 EUR | +0.71% | -6.68% | -19.77% |
Sep. 13 | RTW Biotech half-year net asset value rises amid "challenging markets" | AN |
Sep. 12 | German Shares Advance as ECB Delivers Widely Expected Rate Cut | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
35.59 | +31.92% | 22 | |||||||
995.42 | +7.76% | 25 | |||||||
967.54 | +5.34% | 26 | |||||||
171.32 | +3.51% | 22 | |||||||
196.30 | +1.08% | 27 | |||||||
139.03 | +19.99% | 26 | |||||||
297.08 | +11.85% | 19 | |||||||
183.99 | +17.35% | 20 | |||||||
116.54 | +0.65% | 20 | |||||||
324.71 | -2.33% | 24 | |||||||
33.23 | +13.54% | 22 | |||||||
112.17 | +8.49% | 22 | |||||||
83.54 | +0.88% | 27 | |||||||
53.34 | +8.57% | 21 | |||||||
19.68 | +20.47% | 21 | |||||||
6,663.33 | -0.84% | 15 | |||||||
6,512.50 | +26.83% | 16 | |||||||
3.865 | -1.67% | 17 | |||||||
4,768.83 | +15.27% | 18 | |||||||
Average | 1,140.95 | +9.93% | 22 | ||||||
Weighted average by Cap. | 713.46 | +7.96% | 23 |
- Stock Market
- Equities
- BAYN Stock
- Sector Bayer AG
- Sector consensus